In the last trading session, 1.06 million P3 Health Partners Inc (NASDAQ:PIII) shares changed hands as the company’s beta touched 0.94. With the company’s per share price at $0.18 changed hands at $0.01 or 3.09% during last session, the market valuation stood at $64.73M. PIII’s last price was a discount, traded about -650.0% off its 52-week high of $1.35. The share price had its 52-week low at $0.17, which suggests the last value was 5.56% up since then. When we look at P3 Health Partners Inc’s average trading volume, we note the 10-day average is 0.86 million shares, with the 3-month average coming to 2.18 million.
Analysts gave the P3 Health Partners Inc (PIII) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.80. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended PIII as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. P3 Health Partners Inc’s EPS for the current quarter is expected to be 0.
P3 Health Partners Inc (NASDAQ:PIII) trade information
Instantly PIII was in green as seen at the end of in last trading. With action -8.93%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -19.79%, with the 5-day performance at -8.93% in the red. However, in the 30-day time frame, P3 Health Partners Inc (NASDAQ:PIII) is -13.06% down. Looking at the short shares, we see there were 0.96 million shares sold at short interest cover period of 1.21 days.
P3 Health Partners Inc (PIII) estimates and forecasts
Data shows that the P3 Health Partners Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -71.37% over the past 6 months, a -6.35% in annual growth rate that is considerably lower than the industry average of 24.70%. Year-over-year growth is forecast to reach 19.13% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 378.88M. 2 analysts are of the opinion that P3 Health Partners Inc’s revenue for the current quarter will be 407.15M. The company’s revenue for the corresponding quarters a year ago was 346.86M and 388.49M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 9.23%. The estimates for the next quarter sales put growth at 4.80%.
The 2025 estimates are for P3 Health Partners Inc earnings to increase by 11.08%, but the outlook for the next 5-year period is at 12.64% per year.
PIII Dividends
P3 Health Partners Inc is expected to release its next quarterly earnings report in March.
P3 Health Partners Inc (NASDAQ:PIII)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 23.20% of P3 Health Partners Inc shares while 24.99% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 32.53%. There are 24.99% institutions holding the P3 Health Partners Inc stock share, with ALYESKA INVESTMENT GROUP, L.P. the top institutional holder. As of 2024-06-30, the company held 13.4152% of the shares, roughly 15.95 million PIII shares worth $7.18 million.
ARMISTICE CAPITAL, LLC holds the second largest percentage of outstanding shares, with 6.645% or 7.9 million shares worth $3.56 million as of 2024-06-30.
